A recent study published in *Neurology Open Access* reveals that individuals who have experienced infectious mononucleosis (mono) are about three times more likely to develop multiple sclerosis (MS) compared to those who have not had the infection. This research emphasizes the role of the Epstein-Barr virus (EBV), which infects up to 90-95% of adults worldwide, in potentially triggering autoimmune diseases like MS. The study analyzed over 20 years of health data, finding that 0.17% of those with a history of mono developed MS, compared to 0.07% of those without. While the findings suggest a significant association, researchers caution that mono does not directly cause MS but may act as a trigger in susceptible individuals. Symptoms of mono can include extreme fatigue, fever, sore throat, and swollen lymph nodes, which may last for weeks. The study highlights the need for greater awareness of viral infections and their long-term implications, as well as the potential for developing preventive strategies against EBV. Understanding this connection could lead to new interventions aimed at reducing the risk of chronic diseases associated with viral infections.